Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Ropivacaine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for ropivacaine hydrochloride and what is the scope of ropivacaine hydrochloride patent protection?

Ropivacaine hydrochloride
is the generic ingredient in two branded drugs marketed by Navinta Llc, Aurobindo Pharma Ltd, Sagent Strides, Fresenius Kabi Usa, Akorn Inc, and Hospira, and is included in six NDAs. There are five patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Ropivacaine hydrochloride has sixty-five patent family members in twenty countries.

There are thirteen drug master file entries for ropivacaine hydrochloride. Eight suppliers are listed for this compound.

Summary for Generic Name: ropivacaine hydrochloride

Tradenames:2
Patents:5
Applicants:6
NDAs:6
Drug Master File Entries: see list13
Suppliers / Packagers: see list8
Bulk Api Vendors: see list93
Clinical Trials: see list1,149
Patent Applications: see list4,691
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ropivacaine hydrochloride at DailyMed

Pharmacology for Ingredient: ropivacaine hydrochloride

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
NAROPIN
ropivacaine hydrochloride
SOLUTION;INJECTION020533-003May 1, 1998APRXYesNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
ROPIVACAINE HYDROCHLORIDE
ropivacaine hydrochloride
SOLUTION;INJECTION205612-002Jul 13, 2016APRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
ROPIVACAINE HYDROCHLORIDE
ropivacaine hydrochloride
SOLUTION;INJECTION205612-003Jul 13, 2016APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
NAROPIN
ropivacaine hydrochloride
SOLUTION;INJECTION020533-013May 1, 1998DISCNNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
ROPIVACAINE HYDROCHLORIDE
ropivacaine hydrochloride
SOLUTION;INJECTION205612-005Jul 13, 2016APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot